AI assistant
Sending…
RESMED INC — Director's Dealing 2010
Nov 15, 2010
30071_dirs_2010-11-15_1058f1d8-7866-4c25-ae9b-79b258eb1d8f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2010-11-11
Reporting Person: PENDARVIS DAVID (Sr. VP, General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-11-11 | ResMed Common Stock | F | 2227 | $33.70 | Disposed | 25725.12 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-11-11 | ResMed Common Stock Options | $33.70 | A | 75000 | Acquired | 2017-11-11 | ResMed Common Stock (75000) | Direct |
Footnotes
F1: Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 12/17/2009 and vesting 11/11/2010.
F2: Includes 358.017 shares purchased on October 30, 2010, pursuant to ResMed's Employee Stock Purchase Plan.
F3: Represents first date 1/4 of the options become exercisable. Thereafter, options will continue to vest 1/4 annually until fully vested.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29